Global Financial Private Capital’s AbbVie ABBV Stock Holding History

Global Financial Private Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$10.8M	Sell	109,771 -21,738	-17%	-$1.91M	0.68%	46
2020 Q1	$10M	Sell	131,509 -12,804	-9%	-$1.09M	0.64%	49
2019 Q4	$12.8M	Sell	144,313 -15,043	-9%	-$1.25M	0.64%	47
2019 Q3	$12.1M	Buy	159,356 +1,227	+0.8%	+$84.1K	0.61%	47
2019 Q2	$11.5M	Sell	158,129 -29,498	-16%	-$2.32M	0.55%	55
2019 Q1	$15.1M	Buy	187,627 +20,046	+12%	+$1.64M	0.72%	34
2018 Q4	$15.4M	Sell	167,581 -6,521	-4%	-$573K	0.84%	28
2018 Q3	$16.5M	Sell	174,102 -20,446	-11%	-$1.94M	0.59%	44
2018 Q2	$18M	Buy	194,548 +46	+0%	+$4.49K	0.61%	49
2018 Q1	$18.4M	Sell	194,502 -153,257	-44%	-$16.8M	0.65%	49
2017 Q4	$33.6M	Sell	347,759 -172,215	-33%	-$16.2M	1.15%	24
2017 Q3	$46.2M	Sell	519,974 -49,129	-9%	-$3.74M	1.65%	9
2017 Q2	$41.3M	Sell	569,103 -2,217	-0.4%	-$149K	1.99%	8
2017 Q1	$37.2M	Buy	+571,320	New	+$35.9M	1.87%	10

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Global Financial Private Capital's ABBV Position: Q2 2020 in Review

Global Financial Private Capital reduced its AbbVie (ABBV) stake by 17% in Q2 2020, selling an estimated $1.91M and leaving 109,771 shares worth $10.8M. The position accounts for 0.68% of the portfolio, ranked #46.

Global Financial Private Capital first reported a position in ABBV in Q1 2017 and has held it in 14 quarters since. The position peaked at $46.2M in Q3 2017. 2,412 funds tracked by Wall St. Rank hold ABBV as of Q2 2020.

Global Financial Private Capital held 109,771 shares of AbbVie worth $10.8M as of Q2 2020.
Global Financial Private Capital sold 21,738 AbbVie shares in Q2 2020, an estimated $1.91M.
AbbVie made up 0.68% of Global Financial Private Capital's portfolio in Q2 2020, its #46 holding.
Global Financial Private Capital first reported a position in AbbVie in Q1 2017 and has held it in 14 quarters since.
Global Financial Private Capital's AbbVie position peaked at $46.2M in Q3 2017.
2,412 funds tracked by Wall St. Rank held AbbVie as of Q2 2020.

Based on Global Financial Private Capital's 13F filing for Q2 2020, filed 11 Aug 2020.